课题基金 / 基金详情

CORE--VECTOR 1--ADENOVIRUS/ADENO ASSOCIATED VIRUS HERPESVIRUS LIPOSOME

CORE--VECTOR 1--ADENOVIRUS/ADENO ASSOCIATED VIRUS HERPESVIRUS LIPOSOME
核心--载体1--腺病毒/腺相关病毒疱疹病毒脂质体
批准号:
6355598
负责人:
Neil R. Hackett
金额:
$28.77万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2001-08-31

项目摘要

项目成果

Neil R. Hackett的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core A (Vector 1) will provide assistance in the design, construction and struCtural verification of gene therapy vectors based on adenovirus (Ad), adeno-associated virus (AAV), herpes simplex virus I (HSV). The major role of the core is to provide knowledge and biological materials to the investigators so they may focus on the biological aspects of their projects rather than the technology of gene therapy. For this reason the core will fulfill the following roles: Perform large scale vector preparations for the participating projects (target 50 preparations /year) in accordance with the core usage allocations and resources available; Create new gene therapy vectors by importing improvements in the technology and / or new transgenes that are important for the participating projects (target 18 / year); Provide Standard Operating Procedures for all phases in the construction of all three types of viral vector; Education in construction of vectors through tutorials with senior core scientists and shadowing core technicians; Supply verified samples of biological materials for the vector construction including plasmids, cell lines and starting vectors, and maintain a database describing those materials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Derangements of the Notch Pathway in Airway Epithelial Differentiation in COPD
CORE--ANALYSIS
CORE--DNA VECTOR
Core--Analysis